June 2019 Please note that all data contained within is provisional. The number of cases of measles and rubella officially reported by a member state.

June 2019 Please note that all data contained within is provisional. The number of cases of measles and rubella officially reported by a member state is only available by July of each year (through the joint WHO UNICEF annual data collection exercise). If any numbers from this provisional data are quoted, they should be properly sourced with a date (i.e. "provisional data based on monthly data reported to WHO (Geneva) as of June 2019"). For official data from , please visit our website.

Data source for data contained within this slide deck
The Global Measles and Rubella Report is based on surveillance data reported by Member States to the regional offices weekly or monthly. The regional compilation is reported to HQ monthly. Data are to be reported from the regions on the 1st Friday of the month, and HQ attempts to release the monthly report by the 3rd Monday of the month. Numbers of cases might differ from the official numbers reported annually as part of the WHO/UNICEF Joint reporting process (JRF). The difference can be due to the time lag as the annual data might not be complete at the time of reporting. In addition the difference can be due to multiple surveillance systems at country level. In these cases, the monthly data are extracted from the case based surveillance system while the annual data can be from the aggregated system. Types of data provided to WHO Epidemiologic Data: Case-based and/or Aggregate Reporting to WHO Epidemiologic data comes from Member States in one of two forms Case-based data, which is our recommendation, is provided by most member states. At WHO HQ, we collect a limited set of variables, including, age, date of onset, country reporting, 1st/2nd administrative unit of residence, vaccination status (by recall), date related to specimen collection/testing, and final classification. Regions might or might not collect more data than this. Often suspected cases with recent date of onset are not classified; however, at HQ we classify pending cases as clinically compatible and update the data if/when new data are provided to HQ. For AFR, we classify all cases that are rubella IgM positive as rubella laboratory-confirmed cases. Aggregated data on number of suspected, lab-confirmed, epi-linked, and clinically compatible cases of measles/rubella, by month/year of onset, and by subnational area (though some member states do not provide this level of disaggregation). Source for zero-reporting from some member-states though this is not a consistent process. A few member states send us both case-based and aggregated data as they have two different surveillance systems in the country. If both aggregate and case-based data are sent to HQ, numbers from aggregate surveillance are considered case counts for the country, while case-based data are used for the national slides to show age distribution, proportion vaccinated, and age-specific incidence. Limitations Reporting delays: It can take 2-3 months from the time a case is reported to public health in a member state to the time the data are provided to WHO HQ. Some of this is due to normal reporting delays that are expected as it takes time to get information from a health center to Geneva based on reporting frequencies set by various levels We are working to decrease the delays in reporting. Underreporting/lack of reporting Case definitions for suspect, epidemiologically linked and clinically compatible cases may vary between countries. Completeness of the data reported to WHO is unknown For this monthly update, pending cases are considered measles clinically compatible. These cases may later be discarded or confirmed based on laboratory testing in which case historical case counts may vary from one report to another. This could lead to differences between the Global monthly report and Regional or National surveillance bulletins published by WHO Offices and National authorities. ELISA Laboratory Data from the Global Measles and Rubella Laboratory Network (GMRLN) The Global Measles Rubella Laboratory Network laboratories report the number of samples received as well as the number of samples tested for IgM serology, as well as the number positive, negative and equivocal. These aggregated data are collected to account for the inadequate linking between laboratory and epidemiological data in some countries. Numbers of cases reported may differ from the number of samples tested positive for various reasons Samples tested positive in a laboratory may not reported to the surveillance system IgG screening results are inappropriately included in the surveillance database Inconsistent reporting from laboratories. This is based on the number of SAMPLES tested, not the number of CASES tested. One case can have multiple samples being tested (e.g. different specimen types, repeat specimen collection based on timing of collection). Data are only from network laboratories Non-network laboratories are not included Some laboratories don’t report IgG results are sometimes inappropriately reported Genotyping Data Genotyping data are obtained from the MeaNS ( and RubeNS ( Inadequate sample collection for genotyping challenges interpretation of the data Underreporting WHO recommends that Member States submit genotyping data to these databases, but it is not currently a requirement so there is underreporting Genotype data can’t be linked to epidemiologic data at the global level

Measles

Number of Reported Measles Cases by WHO Regions
2019 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Date Received AFR 41/47 107632 99241 22168 72653 4420 43821 28556 15187 8685 2992 AMR 31/35 7503 1530 110 248 270 375 527 EMR 19/21 15945 9181 5132 771 3278 3019 3583 2301 277 1 EUR 53/53 70997 66647 41491 4417 20739 18946 17816 15746 14133 6 SEAR 11/11 36830 26290 17953 3625 4712 5748 7223 6883 5912 524 WPR 26/27 71500 27115 22066 1000 4049 4902 9690 8164 4355 4 Total 181/194 310407 230004 108810 82466 38728 76546 67116 48551 33737 4054 2018 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Date Received AFR 42/47 81808 55394 14242 33601 7551 2943 4307 5065 3887 2947 1774 1714 1296 1881 5135 9981 14464 AMR 32/35 29682 16689 3 16 84 152 291 204 410 139 645 2609 5952 6184 EMR 20/21 81039 57959 29430 16272 12257 3936 4891 8101 8031 9526 5663 4496 2774 3036 2395 2074 EUR 53/53 97443 84079 50973 4241 28865 5965 7143 7421 7735 8719 7126 5410 3704 2736 5453 9939 12728 SEAR 11/11 107087 83647 58143 18297 7207 8992 9151 14299 12215 10941 5038 3488 3846 3267 4432 3707 4271 WPR 26/27 79592 30530 18254 1742 10534 1924 2479 3388 3228 3051 2424 2221 1950 1926 2611 3028 2300 Total 184/194 476651 328298 171042 74153 83103 23763 27987 38358 35248 35475 22229 17739 13709 13491 23276 35002 42021 Notes: Based on data received This is surveillance data, hence for the last month, the data may be incomplete. * Member States Reporting / Total Member States in Region

Number of Reported Measles Cases by WHO Regions
2019 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Date Received AFR 41/47 107632 99241 22168 72653 4420 43821 28556 15187 8685 2992 AMR 31/35 7503 1530 110 248 270 375 527 EMR 19/21 15945 9181 5132 771 3278 3019 3583 2301 277 1 EUR 53/53 70997 66647 41491 4417 20739 18946 17816 15746 14133 6 SEAR 11/11 36830 26290 17953 3625 4712 5748 7223 6883 5912 524 WPR 26/27 71500 27115 22066 1000 4049 4902 9690 8164 4355 4 Total 181/194 310407 230004 108810 82466 38728 76546 67116 48551 33737 4054 2018 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Date Received AFR 42/47 21980 13648 8856 2485 2307 2903 3636 4203 2058 848 AMR 29/35 5336 1209 3 10 70 73 1053 EMR 20/21 9818 3996 1114 257 2625 1890 785 1040 277 4 EUR 51/53 23799 21478 10898 1043 9537 5564 6335 6743 2779 57 SEAR 11/11 46620 32033 28506 1983 1544 6264 5736 10320 9377 336 WPR 26/27 20617 9271 5783 128 3360 1850 2383 3117 1913 8 Total 179/194 128170 81635 55157 5896 20582 18474 18885 25493 16477 2306 Notes: Based on data received and This is surveillance data, hence for the last month, the data may be incomplete. * Member States Reporting / Total Member States in Region

Measles case distribution by month and WHO Region (2015-2019)
5000 10000 15000 20000 25000 30000 35000 40000 45000 50000 55000 60000 65000 70000 75000 80000 Month of onset Measles cases (Lab+Epi+Clinical) AFR AMR EMR EUR SEAR WPR Notes: Based on data received Data Source: IVB Database - This is surveillance data, hence for the last month(s), the data may be incomplete.

(12M period) Top 10** Country Cases Rate
Madagascar 84929 Ukraine 83533 India**** 47056 35.54 Philippines 34700 335.85 Nigeria 21199 113.98 Pakistan 17805 92.16 Yemen 11984 434.45 Brazil 10231 49.27 Kazakhstan 7349 408.56 Thailand 6960 101.07 Other countries with high incidence rates*** Country Cases Rate Georgia 4997 The Republic of North Macedonia 1370 658.27 Kyrgyzstan 2925 491.12 Israel 3886 474.38 Liberia 1686 365.42 Measles cases from countries with known discrepancies between case-based and aggregate surveillance, as reported by country Country Year Cases in Case-based Cases in Aggregate Data Source for aggregate #s DR Congo 2018 5597 67072 SITUATION EPIDEMIOLOGIQUE DE LA ROUGEOLE EN RDC, Week of 11/06/2019 2019 3907 101,869 Somalia 131 9135 Somali EPI/POL Weekly Update Week 22 28 1834 Notes: Based on data received and covering the period between and Incidence: Number of cases / population* * 100,000 - * World population prospects, revision - ** Countries with the highest number of cases for the period - *** Countries with the highest incidence rates (excluding those already listed in the table above) ****WHO classifies all suspected measles cases reported from India as measles clinically compatible if a specimen was not collected as per the algorithm for classification of suspected measles in the WHO VPD Surveillance Standards. Thus numbers might be different between what WHO reports and what India reports.

(6M period) Top 10* Country Cases Madagascar 82585 Ukraine 60972
Philippines 25661 India** 21914 Nigeria 19780 Kazakhstan 7336 Brazil 6144 Venezuela (Bolivarian Republic of) 5668 Yemen 5643 Myanmar 4663 Notes: Based on data received Surveillance data from to * Countries with highest number of cases for the period. **WHO classifies all suspected measles cases reported from India as measles clinically compatible if a specimen was not collected as per the algorithm for classification of suspected measles in the WHO VPD Surveillance Standards. Thus numbers might be different between what WHO reports and what India reports.

Disclaimer *UN population data is used as the denominator for calculating incidence.

Measles case distribution (AFR), 2015-2019
2000 4000 6000 8000 10000 12000 14000 16000 18000 20000 22000 24000 26000 28000 30000 32000 34000 36000 38000 40000 42000 44000 46000 48000 Month of onset Number of measles cases Uganda Others Nigeria Niger Madagascar Liberia Ghana Ethiopia DR Congo Chad Cameroon DRC has experienced a nationwide epidemic that has affected all Provinces, however, only a small proportion of the measles cases in the IDSR aggregate reporting system are reflected in the case based data. As of 27 May 2013, South Sudan has reassigned to the Africa region (AFR) from the Eastern Mediterranean region (EMR). For data presentation and statistical purposes, South Sudan data is presented in AFR for all the years.

Measles cases: Angola Number of cases Month of onset
500 1000 1500 Discarded Clinical Epi Lab Month of onset Number of cases National (6 M-14 Y) Cov: 93% National SIA Sub-national SIA 200 400 600 800 1000 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Angola age distribution, vaccination status, and incidence, to 50 100 150 250 Incidence rate per 1,000,000 225.5 226.6 81.6 19.9 9.8 3.8 2.1 Year Confirmed Cases 2006 825 2007 245 2008 120 2009 2441 2010 1390 2011 192 2012 4470 2013 6564 2014 12002 2015 103 2016 51 2017 27 2018 57 2019 2820

Measles cases: Cameroon
100 200 300 400 500 Discarded Clinical Epi Lab Month of onset Number of cases Sub-national (9-59 M) Cov: 88% National SIA Sub-national SIA 200 400 600 800 1000 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Cameroon age distribution, vaccination status, and incidence, to 100 300 Incidence rate per 1,000,000 296.9 302.7 84.7 28.3 9.9 5.7 1.5 Year Confirmed Cases 2006 192 2007 96 2008 494 2009 870 2010 228 2011 909 2012 616 2013 774 2014 765 2015 1872 2016 658 2017 710 2018 896 2019 1148

Measles cases: Chad There is a large amount of underreporting. As of Week 22, there are 19,724 suspected cases of measles and 198 deaths 200 400 600 800 Discarded Clinical Epi Lab Month of onset Number of cases Sub-national (6-9 Y) Cov: 100% National SIA Sub-national SIA 200 400 600 800 1000 1200 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Chad age distribution, vaccination status, and incidence, to 100 300 500 Incidence rate per 1,000,000 511.6 509.3 210.9 124.3 87.3 62 14.4 Year Confirmed Cases 2006 15 2007 65 2008 70 2009 632 2010 219 2011 156 2012 153 2013 217 2014 1251 2015 418 2016 168 2017 26 2018 1079 2019 1528

Measles cases: Democratic Republic of the Congo
1000 2000 Discarded Clinical Epi Lab Month of onset Number of cases Due to surveillance gaps, case-based data is a poor representation of the current situation in DRC 1000 2000 3000 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Democratic Republic of the Congo age distribution, vaccination status, and incidence, to 50 100 150 200 250 300 Incidence rate per 1,000,000 255.9 250.1 87.2 19.6 9 5.2 1 Year Confirmed Cases 2006 1012 2007 539 2008 214 2009 83 2010 208 2011 1651 2012 2332 2013 2527 2014 1649 2015 5029 2016 4860 2017 3597 2018 5597 2019 3907

Measles cases: Ethiopia
100 200 300 400 500 600 Discarded Clinical Epi Lab Month of onset Number of cases Sub-national (6-179 M) Cov: 98% National SIA Sub-national SIA Cases are occurring but data has not been reported to WHO. > 4000 cases since Oct 2018 50 100 150 200 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Ethiopia age distribution, vaccination status, and incidence, to 10 20 Incidence rate per 1,000,000 18.5 16.8 8.2 5.3 8.7 6.8 1 Year Confirmed Cases 2006 1278 2007 1472 2008 3161 2009 2642 2010 6205 2011 3552 2012 4616 2013 6137 2014 14282 2015 17778 2016 4568 2017 1912 2018 1351

Measles cases: Madagascar
There is a large amount of underreporting. As of May 26, there were 146,277 cases of measles and 1022 deaths, the epicurve is trending downwards 10000 20000 30000 40000 Discarded Clinical Epi Lab Month of onset Number of cases Sub-national (9 M-14 Y) Cov: 94% National SIA Sub-national SIA 5000 10000 15000 20000 25000 30000 35000 40000 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Madagascar age distribution, vaccination status, and incidence, to 1000 2000 3000 4000 6000 7000 8000 9000 11000 12000 13000 14000 16000 17000 18000 19000 21000 22000 23000 24000 26000 27000 28000 29000 31000 32000 33000 34000 36000 37000 38000 39000 41000 42000 43000 44000 45000 46000 47000 48000 49000 50000 51000 52000 53000 Incidence rate per 1,000,000 3126.8 2502.1 2199.2 1147.3 600.8 843.2 Year Confirmed Cases 2006 2 2007 2008 12 2009 2010 1 2011 2012 3 2013 7 2014 2015 6 2016 17 2017 84 2018 23558 2019 61401

Measles cases: Nigeria
2000 4000 6000 8000 Discarded Clinical Epi Lab Month of onset Number of cases National (9-59 M) Cov: 107% Cov: 106% National SIA Sub-national SIA 5000 10000 15000 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Nigeria age distribution, vaccination status, and incidence, to 100 200 300 400 500 Incidence rate per 1,000,000 415.4 497.6 159.9 54.9 14.3 5.2 3.4 Year Confirmed Cases 2006 1019 2007 3129 2008 10453 2009 1498 2010 9072 2011 19062 2012 6423 2013 55392 2014 6850 2015 12391 2016 17581 2017 11188 2018 7018 2019 20524

Measles case distribution (AMR), 2015-2019
500 1000 1500 2000 2500 3000 3500 4000 4500 5000 5500 6000 6500 Month of onset Number of measles cases Venezuela (Bolivarian Republic of) USA Peru Others Mexico Costa Rica Colombia Chile Canada Brazil Argentina Notes: Based on data received Data Source: IVB Database

Measles cases: Venezuela (Bolivarian Republic of)
Aggregation of cases at a specific time point is an artifact of reporting 2000 4000 6000 Discarded Clinical Epi Lab Month of onset Number of cases National (6 M-15 Y) Cov: 94% National SIA Sub-national SIA 200 400 600 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Venezuela (Bolivarian Republic of) age distribution, vaccination status, and incidence, to 800 Incidence rate per 1,000,000 718.3 255.9 66.4 51.4 21.2 7.9 3.9 Year Confirmed Cases 2008 2009 2010 2011 2012 1 2013 2014 2015 2016 2017 727 2018 5668 2019 203

Measles case distribution (EMR), 2015-2019
500 1000 1500 2000 2500 3000 3500 4000 4500 5000 5500 6000 6500 7000 7500 8000 8500 9000 9500 10000 Month of onset Number of measles cases Yemen United Arab Emirates Sudan Saudi Arabia Pakistan Others Libya Lebanon Iraq Egypt Afghanistan Notes: Based on data received Data Source: IVB Database

Measles cases: Pakistan
2000 4000 6000 8000 Discarded Clinical Epi Lab Month of onset Number of cases National SIA Sub-national SIA 5000 10000 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Pakistan age distribution, vaccination status, and incidence, to 200 400 600 800 1000 Incidence rate per 1,000,000 885.4 466.1 147.4 26.9 3.8 1.2 0.2 Year Confirmed Cases 2006 35 2007 33 2008 53 2009 472 2010 1111 2011 2676 2012 8048 2013 8030 2014 1370 2015 1117 2016 2806 2017 6780 2018 32921 2019 962

Measles cases: Sudan Number of cases Month of onset
200 400 600 800 1000 Discarded Clinical Epi Lab Month of onset Number of cases 1000 2000 3000 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Sudan age distribution, vaccination status, and incidence, to 200 400 600 800 Incidence rate per 1,000,000 943.1 562.3 193.7 62.6 62.9 57.7 8.7 Year Confirmed Cases 2006 274 2007 483 2008 97 2009 68 2010 613 2011 5616 2012 8521 2013 2811 2014 676 2015 3585 2016 1767 2017 665 2018 4978 2019 2133

Measles cases: Yemen Number of cases Month of onset
1000 2000 Discarded Clinical Epi Lab Month of onset Number of cases 2000 4000 6000 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Yemen age distribution, vaccination status, and incidence, to 500 1000 1500 2500 Incidence rate per 1,000,000 2320.1 1910 798.1 183.9 55 52.5 8.6 Year Confirmed Cases 2006 4989 2007 50 2008 53 2009 127 2010 372 2011 847 2012 2143 2013 571 2014 817 2015 465 2016 143 2017 2101 2018 13622 2019 3470

Measles case distribution (EUR), 2015-2019
1000 2000 3000 4000 5000 6000 7000 8000 9000 10000 11000 12000 13000 14000 15000 16000 17000 18000 19000 20000 Month of onset Number of measles cases Ukraine Serbia Russian Federation Romania Others Kyrgyzstan Kazakhstan Italy Germany Georgia France Notes: Based on data received Data Source: IVB Database

Measles cases: Georgia
200 400 600 800 1000 1200 1400 Discarded Clinical Epi Lab Month of onset Number of cases 500 1000 1500 2000 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Georgia age distribution, vaccination status, and incidence, to 3000 4000 5000 6000 7000 8000 9000 10000 11000 12000 Incidence rate per 1,000,000 3233.3 1185.9 1485.9 1851 1867.7 266.1 Year Confirmed Cases 2006 8 2007 2 2008 55 2009 23 2010 22 2011 64 2012 30 2013 7868 2014 3190 2015 430 2016 14 2017 96 2018 2203 2019 3457

Measles cases: Kazakhstan
1000 2000 Discarded Clinical Epi Lab Month of onset Number of cases 500 1000 1500 2000 2500 <1 year 1-4 years 5-9 years 10-14 years 15-19 years 20-29 years 30+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Kazakhstan age distribution, vaccination status, and incidence, to 3000 4000 5000 6000 7000 Incidence rate per 1,000,000 6329.9 1520.5 253.9 143.7 64.8 235.8 140.7 Year Confirmed Cases 2006 87 2007 6 2008 24 2009 2011 30 2012 109 2013 73 2014 317 2015 2340 2016 110 2017 2 2018 576 2019 6774

Measles cases: Kyrgyzstan
200 400 600 800 Discarded Clinical Epi Lab Month of onset Number of cases 500 1000 1500 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Kyrgyzstan age distribution, vaccination status, and incidence, to 2000 3000 4000 5000 6000 7000 8000 9000 10000 Incidence rate per 1,000,000 8604.9 1650.1 230.9 84.9 191.8 95 40.1 Year Confirmed Cases 2006 26 2007 2 2008 16 2009 2010 1 2011 210 2012 2013 2014 318 2015 17779 2016 2017 5 2018 1104 2019 1969

Measles cases: The Republic of North Macedonia
100 200 300 400 500 Discarded Clinical Epi Lab Month of onset Number of cases 200 400 600 <1 year 1-4 years 5-9 years 10-14 years 15-19 years 20-29 years 30+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases The Republic of North Macedonia age distribution, vaccination status, and incidence, to 1000 2000 3000 4000 5000 6000 7000 8000 9000 10000 11000 Incidence rate per 1,000,000 9795.5 2419.6 490.3 200.2 135.8 414.5 627.4 Year Confirmed Cases 2006 2007 2008 28 2009 3 2010 209 2011 731 2012 6 2013 4 2014 107 2015 1 2016 2017 20 2018 64 2019 1314

Measles cases: Russian Federation
200 400 600 800 1000 1200 Discarded Clinical Epi Lab Month of onset Number of cases 200 400 600 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Russian Federation age distribution, vaccination status, and incidence, to 20 40 60 80 100 Incidence rate per 1,000,000 84.6 82 46.9 30.7 21.9 18.1 5.8 Year Confirmed Cases 2006 1129 2007 172 2008 27 2009 101 2010 152 2011 783 2012 1975 2013 2501 2014 3263 2015 635 2016 179 2017 897 2018 2256 2019 1627

Measles cases: Ukraine
5000 10000 15000 Discarded Clinical Epi Lab Month of onset Number of cases National SIA Sub-national SIA 5000 10000 15000 20000 <1 year 1-4 years 5-9 years 10-14 years 15-19 years 20-29 years 30+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Ukraine age distribution, vaccination status, and incidence, to 1000 2000 3000 4000 6000 7000 8000 9000 Incidence rate per 1,000,000 8291.5 5761.8 6574.1 6371 1944.7 1320.1 759.4 Year Confirmed Cases 2006 945 2007 232 2008 41 2009 24 2010 42 2011 1313 2012 12744 2013 3308 2014 2326 2015 141 2016 90 2017 4782 2018 53218 2019 42874

Measles case distribution (SEAR (excl. India)), 2015-2019
500 1000 1500 2000 2500 3000 3500 Month of onset Number of measles cases Timor-Leste Thailand Sri Lanka Nepal Myanmar Maldives Indonesia DPR Korea Bhutan Bangladesh Notes: Based on data received Data Source: IVB Database

Measles cases: Indonesia
1000 2000 3000 Discarded Clinical Epi Lab Month of onset Number of cases Sub-national (9 M-15 Y) Cov: 101% Cov: 73% National SIA Sub-national SIA 50 100 150 200 250 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Indonesia age distribution, vaccination status, and incidence, to 5 10 15 Incidence rate per 1,000,000 14.2 7.9 8.9 2.8 1.9 0.4 Year Confirmed Cases 2006 21911 2007 20837 2008 16417 2009 21008 2010 23471 2011 23510 2012 16786 2013 10093 2014 9498 2015 6209 2016 7204 2017 11389 2018 5389 2019 463

Measles cases: Myanmar
500 1000 1500 Discarded Clinical Epi Lab Month of onset Number of cases 500 1000 1500 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Myanmar age distribution, vaccination status, and incidence, to 100 200 300 400 600 Incidence rate per 1,000,000 526.9 407 212.1 72.5 99.5 44.7 2.4 Year Confirmed Cases 2006 760 2007 1087 2008 334 2009 501 2010 432 2011 1810 2012 2164 2013 1000 2014 110 2015 6 2016 274 2017 1246 2018 1391 2019 4095

Measles case distribution (SEAR, India*), 2015-2019
5000 10000 15000 Month of onset Number of measles cases India Notes: Based on data received Data Source: IVB Database *WHO classifies all suspected measles cases reported from India as measles clinically compatible if a specimen was not collected as per the algorithm for classification of suspected measles in the WHO VPD Surveillance Standards. Thus numbers might be different between what WHO reports and what India reports.

Measles cases: India* Number of cases Month of onset
10000 20000 30000 Discarded Clinical Epi Lab Month of onset Number of cases National SIA Sub-national SIA 2000 4000 6000 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases India age distribution, vaccination status, and incidence, to 20 40 60 80 Incidence rate per 1,000,000 79.4 63.5 40.6 12.6 5.2 1.8 0.2 Year Confirmed Cases 2014 80306 2015 83026 2016 70798 2017 61288 2018 69391 2019 17402 *WHO classifies all suspected measles cases reported from India as measles clinically compatible if a specimen was not collected as per the algorithm for classification of suspected measles in the WHO VPD Surveillance Standards. Thus numbers might be different between what WHO reports and what India reports.

Measles cases: Thailand
1000 2000 Discarded Clinical Epi Lab Month of onset Number of cases 500 1000 1500 2000 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Thailand age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 1715 613.2 218.5 109.5 127.4 79.2 5.1 Year Confirmed Cases 2006 3962 2007 3517 2008 6339 2009 5272 2010 2273 2011 2873 2012 4072 2013 2056 2014 834 2015 190 2016 1009 2017 2033 2018 4938 2019 2754

Measles case distribution (WPR), 2015-2019
2000 4000 6000 8000 10000 12000 14000 16000 18000 Month of onset Number of measles cases Viet Nam Singapore Republic of Korea Philippines Others New Zealand Mongolia Malaysia Japan China Australia Notes: Based on data received Data Source: IVB Database

Measles cases: Philippines
5000 10000 15000 Discarded Clinical Epi Lab Month of onset Number of cases Sub-national (6-59 M) Cov: 69% Cov: 32% National SIA Sub-national SIA 5000 10000 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Philippines age distribution, vaccination status, and incidence, to 1000 2000 3000 4000 Incidence rate per 1,000,000 4992.3 1180.9 208.4 112.5 254.6 153.8 17.4 Year Confirmed Cases 2006 216 2007 612 2008 838 2009 1351 2010 6363 2011 6519 2012 1441 2013 4855 2014 53906 2015 2021 2016 647 2017 2409 2018 20764 2019 21749

Measles cases: Viet Nam
200 400 600 800 1000 1200 Discarded Clinical Epi Lab Month of onset Number of cases 500 1000 1500 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Viet Nam age distribution, vaccination status, and incidence, to 200 400 600 800 Incidence rate per 1,000,000 869.3 258.2 112.7 22.1 17.1 29.2 2.6 Year Confirmed Cases 2006 1972 2007 17 2008 259 2009 5218 2010 1826 2011 745 2012 636 2013 1308 2014 16606 2015 884 2016 520 2017 591 2018 2766 2019 2580

(last 12 months) Notes: Data Source: MeaNS database (Genotypes) and IVB Database (Incidence) as of and covering the period to Pie charts proportional to the number of sequenced viruses

Rubella

Number of Reported Rubella Cases by WHO Regions
2019 Region Member States* Rubella cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Date Received AFR 37/47 1269 206 248 477 290 48 AMR 26/35 2 EMR 18/21 547 3 544 45 98 151 253 EUR 29/53 288 224 6 58 75 71 67 SEAR 11/11 978 169 258 396 137 18 WPR 13/27 13400 1228 639 11533 1141 1280 4140 6839 Total 134/194 16484 1455 645 14384 1636 1959 5235 7588 66 2018 Region Member States* Rubella cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Date Received AFR 42/47 3387 345 367 571 373 353 261 223 226 177 203 175 113 AMR 27/35 2 1 EMR 20/21 1521 149 313 1059 151 173 242 206 115 83 71 80 46 35 EUR 36/53 846 736 7 103 82 96 75 90 61 73 50 42 49 52 SEAR 11/11 4275 1305 2970 327 481 836 931 526 194 130 189 222 145 88 WPR 14/27 4401 359 114 3928 105 95 276 493 757 341 264 220 287 339 408 816 Total 150/194 14432 1244 1739 11449 1010 1213 2000 2100 1932 991 791 807 870 823 1104 Notes: Based on data received This is surveillance data, hence for the last month, the data may be incomplete. * Member States Reporting / Total Member States in Region

Number of Reported Rubella Cases by WHO Regions
2019 Region Member States* Rubella cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Date Received AFR 37/47 1269 206 248 477 290 48 AMR 26/35 2 EMR 18/21 547 3 544 45 98 151 253 EUR 29/53 288 224 6 58 75 71 67 SEAR 11/11 978 169 258 396 137 18 WPR 13/27 13400 1228 639 11533 1141 1280 4140 6839 Total 134/194 16484 1455 645 14384 1636 1959 5235 7588 66 2018 Region Member States* Rubella cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Date Received AFR 40/47 1376 308 244 464 281 79 AMR 23/35 1 EMR 19/21 247 4 243 64 87 90 6 EUR 26/53 227 195 31 52 54 57 SEAR 11/11 884 45 839 224 245 263 130 22 WPR 14/27 887 105 8 774 111 98 260 418 Total 133/194 3622 304 3264 759 729 1134 899 101 Notes: Based on data received and This is surveillance data, hence for the last month, the data may be incomplete. * Member States Reporting / Total Member States in Region

Rubella Case Distribution by Month and WHO Region (2015-2019)
500 1000 1500 2000 2500 3000 3500 4000 4500 5000 5500 6000 6500 7000 7500 8000 Month of onset Rubella cases (Lab+Epi+Clinical) WPR SEAR EUR EMR AMR AFR Notes: Based on data received Data Source: IVB Database - This is surveillance data, hence for the last month(s), the data may be incomplete.

Other countries with high incidence rates***
(12M period) Top 10** Country Cases Rate China 15014 10.700 Japan 1492 11.680 India 1263 0.950 Indonesia 1027 3.930 Nigeria 905 4.870 Pakistan 646 3.340 Poland 421 11.010 Uganda 390 9.400 DR Congo 336 4.270 South Africa 319 5.690 Other countries with high incidence rates*** Country Cases Rate Central African Republic 111 24.160 Congo 101 19.700 Yemen 282 10.220 Liberia 44 9.540 Malaysia 174 5.580 Notes: Based on data received and covering the period between and Incidence: Number of cases / population* * 100,000 - * World population prospects, 2017 revision - ** Countries with the highest number of cases for the period - *** Countries with the highest incidence rates (excluding those already listed in the table above)

Rubella cases: AFR 600 400 200 500 400 Number of cases (IgM+ only) 300
200 400 600 Not introduced in EPI Introduced <5 years ago (after 2013) Introduced >=5 years ago (2013 and before) Month of onset Number of cases (IgM+ only) AFR Rubella Case Distribution (June 2017-May 2019) Top 10 countries (last 12 M) label RCV in RI Cases % of Total Nigeria No 865 33 Uganda 386 15 DR Congo 330 12 Others - 287 11 South Africa 269 10 Ethiopia 140 5 Central African Republic 116 4 Mozambique 2018 88 3 Congo 79 Liberia 44 2 Angola 43 100 200 300 400 500 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017 Age at onset (in years) Number of cases (IgM+ only) AFR Age distribution of Rubella IgM+ cases by vaccine introduction status in the National EPI Programme (June 2018-May 2019) Notes: Based on data received Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31 Dec 2016.

Rubella cases: EMR 300 200 100 (lab + epi-linked + clinical) 150
100 200 300 Not introduced in EPI Introduced <5 years ago (after 2013) Introduced >=5 years ago (2013 and before) Month of onset Number of cases (lab + epi-linked + clinical) EMR Rubella Case Distribution (June 2017-May 2019) Top 10 countries (last 12 M) label RCV in RI Cases % of Total Pakistan No 521 48 Yemen 2015 249 23 Sudan 136 12 United Arab Emirates 1985 36 3 Tunisia 2004 35 Saudi Arabia 1991 34 Afghanistan 2018 31 Others - 14 1 Iran (Islamic Republic of) Libya 1995 Morocco 2014 10 50 100 150 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017 Age at onset (in years) Number of cases (lab + epi-linked + clinical) EMR Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (June 2018-May 2019) Notes: Based on data received Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31 Dec 2016.

Rubella cases: EUR 100 80 60 40 20 200 (lab + epi-linked + clinical)
20 40 60 80 100 Not introduced in EPI Introduced <5 years ago (after 2013) Introduced >=5 years ago (2013 and before) Month of onset Number of cases (lab + epi-linked + clinical) EUR Rubella Case Distribution (June 2017-May 2019) Top 10 countries (last 12 M) label RCV in RI Cases % of Total Poland 1988 363 52 Ukraine 2001 180 26 Germany 1991 51 7 Others - 19 3 Turkey 2006 Italy 1972 17 2 Russian Federation 2000 Spain 1978 13 Romania 2002 6 1 Georgia 2004 5 Portugal 1984 100 200 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017 Age at onset (in years) Number of cases (lab + epi-linked + clinical) EUR Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (June 2018-May 2019) Notes: Based on data received Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31 Dec Spikes in age-distribution curve are an artifact of reporting by age bands ( 0=<1 yrs, 2=1-4 yrs, 7=5-9 yrs, 12=10-14 yrs, 17=15-19 yrs, 25=20-29 yrs, 45=30+yrs) instead of by age from some member states.

Rubella cases: SEAR (excl. India)
100 200 300 400 500 600 Not introduced in EPI Introduced <5 years ago (after 2013) Introduced >=5 years ago (2013 and before) Month of onset Number of cases (lab + epi-linked + clinical) SEAR (excl. India) Rubella Case Distribution (June 2017-May 2019) Top 10 countries (last 12 M) label RCV in RI Cases % of Total Indonesia No 912 75 Bangladesh 2012 158 13 Thailand 1993 107 9 Nepal 2013 30 2 Myanmar 2015 15 1 Timor-Leste 2016 100 200 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017 Age at onset (in years) Number of cases (lab + epi-linked + clinical) SEAR (excl. India) Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (June 2018-May 2019) Notes: Based on data received Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31 Dec 2016.

Rubella cases: SEAR, India
200 400 600 Not introduced in EPI Introduced <5 years ago (after 2013) Introduced >=5 years ago (2013 and before) Month of onset Number of cases (lab + epi-linked + clinical) SEAR, India Rubella Case Distribution (June 2017-May 2019) Top 10 countries (last 12 M) label RCV in RI Cases % of Total India No 928 100 50 100 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017 Age at onset (in years) Number of cases (lab + epi-linked + clinical) SEAR, India Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (June 2018-May 2019) Notes: Based on data received Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31 Dec 2016.

Rubella cases: Thailand
10 20 30 Clinical Epi Lab Number of cases Year Confirmed Cases 2015 36 2016 7 2017 24 2018 52 2019 68 5 10 15 20 25 30 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years Male Female Unknown Age at onset Number of cases Thailand age distribution, sex, and incidence, to Incidence rate per 1,000,000 29.7 3.6 0.5 1.2 2.5 1.6 0.4

Rubella cases: WPR 2000 4000 6000 8000 Not introduced in EPI Introduced <5 years ago (after 2013) Introduced >=5 years ago (2013 and before) Month of onset Number of cases (lab + epi-linked + clinical) WPR Rubella Case Distribution (June 2017-May 2019) Top 10 countries (last 12 M) label RCV in RI Cases % of Total China 2008 14299 89 Japan 1989 1489 9 Malaysia 1998 157 1 Philippines 2010 67 Viet Nam 2015 22 Cambodia 2013 14 Singapore 1990 13 Lao People's Democratic Republic 2012 Papua New Guinea 2 Republic of Korea 1982 Others - 100 200 300 400 500 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017 Age at onset (in years) Number of cases (lab + epi-linked + clinical) WPR (Excl. China) Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (June 2018-May 2019) Notes: Based on data received Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31 Dec 2016.

Rubella cases: China 8000 Number of cases 6000 4000 2000
2000 4000 6000 8000 Clinical Epi Lab Number of cases Year Confirmed Cases 2014 11887 2015 8247 2016 4477 2017 1601 2018 3947 2019 11882

Rubella cases: Japan There is underreporting of rubella cases to WHO from Japan. As of week 22, there are 1658 cases, with 30 new cases in . The latest data is available here. 100 200 300 400 500 Clinical Epi Lab Number of cases Year Confirmed Cases 2014 2015 2 2016 3 2017 5 2018 68 2019 1425 200 400 600 800 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years Male Female Unknown Age at onset Number of cases Japan age distribution, sex, and incidence, to 10 20 30 Incidence rate per 1,000,000 3.9 2.8 1.3 2.7 15.7 26.2 8.9

Rubella cases: Philippines
20 40 60 80 100 Clinical Epi Lab Number of cases SIA (6-59 M) Cov: 69% Cov: 32% National SIA Sub-national SIA Year Confirmed Cases 2014 343 2015 154 2016 165 2017 474 2018 129 2019 29 10 20 30 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years Male Female Unknown Age at onset Number of cases Philippines age distribution, sex, and incidence, to 5 Incidence rate per 1,000,000 10.9 1.3 0.3 0.9 0.7 0.2

Rubella cases: Viet Nam
10 20 Clinical Epi Lab Number of cases Year Confirmed Cases 2014 193 2015 765 2016 301 2017 83 2018 40 2019 2 2 4 6 8 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years Male Female Unknown Age at onset Number of cases Viet Nam age distribution, sex, and incidence, to 1 3 Incidence rate per 1,000,000 2.6 0.4 0.2 0.3 0.1

(last 12 months) Notes: Data Source: RubNS database (Genotypes) and IVB Database (Incidence) as of and covering the period to Pie charts proportional to the number of sequenced viruses

Laboratory

Measles and Rubella IgM Data Summary
2019 Region Member States* Specimens received Measles tested Measles positive n(%) Measles equivocal n(%) Measles negative n(%) Rubella tested Rubella positive n(%) Rubella equivocal n(%) Rubella negative n(%) AFR 34/47 15120 5442 (36) 437 (3) 9241 (61) 9006 1548 (17) 472 (5) 6986 (78) AMR 27/35 5692 4942 306 (6) 75 (2) 4410 (89) 4516 292 (6) 153 (3) 3924 (87) EMR 19/21 8556 6180 2324 (38) 32 (1) 3824 (62) 5312 143 (3) 28 (1) 5141 (97) EUR 37/53 61572 56161 25928 (46) 529 (1) 28699 (51) 29074 830 (3) 109 (0) 28112 (97) SEAR 11/11 17863 15805 6412 (41) 310 (2) 9172 (58) 9818 1074 (11) 256 (3) 8622 (88) WPR 27/27 23266 21790 4278 (20) 247 (1) 8369 (38) 16200 940 (6) 207 (1) 6033 (37) Total 155/194 132069 119998 44690 (37) 1630 (1) 63715 (53) 73926 4827 (7) 1225 (2) 58818 (80) 2018 Region Member States* Specimens received Measles tested Measles positive n(%) Measles equivocal n(%) Measles negative n(%) Rubella tested Rubella positive n(%) Rubella equivocal n(%) Rubella negative n(%) AFR 41/47 48178 10084 (21) 1252 (3) 36842 (76) 37104 5004 (13) 2065 (6) 30035 (81) AMR 29/35 18420 18202 1459 (8) 194 (1) 16118 (89) 15563 496 (3) 353 (2) 14312 (92) EMR 20/21 60673 36544 12960 (35) 168 (0) 23416 (64) 33310 1725 (5) 361 (1) 31224 (94) EUR 38/53 120470 109966 36776 (33) 644 (1) 71986 (65) 71582 1382 (2) 248 (0) 69904 (98) SEAR 11/11 34075 31209 11945 (38) 790 (3) 18454 (59) 20872 2561 (12) 519 (2) 17792 (85) WPR 27/27 34896 30327 5630 (19) 570 (2) 14368 (47) 24972 646 (3) 456 (2) 12961 (52) Total 166/194 316712 274426 78854 (29) 3618 (1) (66) 203403 11814 (6) 4002 (2) (87) Notes: Based on data received * Member States Reporting / Total Member States in Region

Measles and Rubella IgM Data Summary
Data as of June 2019 2019 Region Member States* Specimens received Measles tested Measles positive n(%) Measles equivocal n(%) Measles negative n(%) Rubella tested Rubella positive n(%) Rubella equivocal n(%) Rubella negative n(%) AFR 34/47 15120 5442 (36) 437 (3) 9241 (61) 9006 1548 (17) 472 (5) 6986 (78) AMR 27/35 5692 4942 306 (6) 75 (2) 4410 (89) 4516 292 (6) 153 (3) 3924 (87) EMR 19/21 8556 6180 2324 (38) 32 (1) 3824 (62) 5312 143 (3) 28 (1) 5141 (97) EUR 37/53 61572 56161 25928 (46) 529 (1) 28699 (51) 29074 830 (3) 109 (0) 28112 (97) SEAR 11/11 17863 15805 6412 (41) 310 (2) 9172 (58) 9818 1074 (11) 256 (3) 8622 (88) WPR 27/27 23266 21790 4278 (20) 247 (1) 8369 (38) 16200 940 (6) 207 (1) 6033 (37) Total 155/194 132069 119998 44690 (37) 1630 (1) 63715 (53) 73926 4827 (7) 1225 (2) 58818 (80) Data as of June 2018 2018 Region Member States* Specimens received Measles tested Measles positive n(%) Measles equivocal n(%) Measles negative n(%) Rubella tested Rubella positive n(%) Rubella equivocal n(%) Rubella negative n(%) AFR 35/47 9640 2058 (21) 232 (2) 7350 (76) 6914 1178 (17) 401 (6) 5335 (77) AMR 26/35 5720 5387 304 (6) 48 (1) 4748 (88) 4990 223 (4) 124 (2) 4346 (87) EMR 20/21 9527 8936 2934 (33) 14 (0) 5988 (67) 7432 326 (4) 27 (0) 7079 (95) EUR 36/53 23068 21333 6975 (33) 149 (1) 14045 (66) 11411 254 (2) 19 (0) 11119 (97) SEAR 11/11 10203 7125 2754 (39) 226 (3) 4141 (58) 4651 841 (18) 148 (3) 3658 (79) WPR 27/27 9159 8525 1605 (19) 173 (2) 4280 (50) 6725 181 (3) 109 (2) 3258 (48) Total 155/194 67317 60946 16630 (27) 842 (1) 40552 (67) 42123 3003 (7) 828 (2) 34795 (83) Notes: Based on data received and * Member States Reporting / Total Member States in Region

Performance of Surveillance

Surveillance sensitivity reporting rate of measles and rubella (12 months, discarded cases* per 100,000 population) Notes: Based on data received and covering the period between and Target: >= 2 discarded cases* / 100,000 population** - * Suspected cases investigated and discarded as non- measles non-rubella using laboratory testing and/or epidemiological linkage to another etiology ** World population prospects, 2017 revision

Supplementary Immunization Activities

Next 6 months MMR, MR and Measles campaigns
Region Name Activity Type Year StartDate EndDate Age Group(s) Extent Target AFR Sierra Leone CatchUp MR 2019 9 M-14 Y National SEAR India - 9 M-15 Y Rollover-Nat 180000 Democratic Republic of the Congo (the) FollowUp Measles 6-59 M Sub-national Kenya 9 M-5 Y Niger (the) 9-59 M Nigeria United Republic of Tanzania AMR Guatemala Campaign MMR 1-6 Y WPR Solomon Islands 1-4 Y 68173 Zimbabwe Uganda 9 M->15 Y Madagascar Bangladesh Democratic People's Republic of Korea (the) Myanmar Nepal Cameroon Central African Republic (the) unknown 837841 Guinea South Sudan EMR Egypt NIDs 9 M-<6 Y 1.8e+07 Somalia 6 M-5 Y Burkina Faso

Regional Bulletins and Newsletters

June 2019 Please note that all data contained within is provisional. The number of cases of measles and rubella officially reported by a member state.

Similar presentations

Presentation on theme: "June 2019 Please note that all data contained within is provisional. The number of cases of measles and rubella officially reported by a member state."— Presentation transcript:

Similar presentations

About project

Feedback

Log in

Auth with social network:

June 2019 Please note that all data contained within is provisional. The number of cases of measles and rubella officially reported by a member state.

Similar presentations

Presentation on theme: "June 2019 Please note that all data contained within is provisional. The number of cases of measles and rubella officially reported by a member state."— Presentation transcript:

Similar presentations

About project

Feedback